The complex world of efficacy trial programs and meeting national requirements
![Sidebar Image](https://cdnmedia.eurofins.com/corporate-eurofins/media/1010/resourcecenter_header.jpg)
In this article, senior regulatory expert Nadja Liebig explores the complexities of national requirements in terms of efficacy trial programs across Europe - depending on the product, the uses and the countries for which registration is sought, dossiers containing more than 100 trials are very common ...